Preclinical Research

  • Preclinical Research
  • I recently returned from attending the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting. This was my first conference since joining Altasciences, and I was excited to attend with some of my esteemed colleagues, Nobert Makori (Vice President of Toxicology), Steve Mason (Co-COO), and members of the Business Development team, Derek Storey, Gretchen Green, Todd Hartz, and Mike Zamora.

    ARVO 2025 was held in Salt Lake City

    Altasciences recently attended and exhibited at the 2025 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, held at the Salt Palace Convention Center against the stunning backdrop of downtown Salt Lake City, Utah—arguably one of the most scenic U.S. conference locations.

    By Martin Rougée, Optimization Scientist, Bioanalytical Operations

    Automation offers several advantages to any industry. For a contract research organization (CRO), it can play an integral role in increasing the quality and speed of drug development while reducing costs, repetitive manual tasks, and human error. For biotechnology and pharmaceutical companies, automation can decrease their drug-to-market development time and remain financially competitive in an evolving market.

    The 17th Minipig Research Forum took place in Amsterdam, Netherlands.

    I recently had the chance to attend the 17th Minipig Research Forum (MRF) in Amsterdam—and what an experience! This was my first time attending the forum, and visiting the Netherlands!

    Some might say a reflective piece like this could come across as sounding “preachy”. Maybe it is. But it is reflective of a long and rewarding career built on the belief that we as scientists need to give back to the field of toxicology, supporting the growth of future leaders.  

    Dr. Marianna Bacellar-Galdino receives the award for best ocular poster

    I had a fantastic time connecting with colleagues, clients, and peers at the Society of Toxicology (SOT) 64th Annual Meeting in Orlando, Florida. As my first SOT experience, I truly enjoyed the vibrant, enthusiastic atmosphere.

    For emerging therapies with pronounced pharmacological effects, thoughtful study design is critical to ensuring reliable and interpretable data.

    Hybridization LC-MS/MS for Sensitive Quantitation of Antisense Oligonucleotides in Plasma and Dried Blood Microsamples

    Dose range finding (DRF) studies are the foundation of preclinical drug development, providing crucial information on safety data to assist in the dose level selection before advancing into to

    Subscribe to Preclinical Research